mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.009 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |